{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:35:30Z","timestamp":1788550530395,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573676"],"award-info":[{"award-number":["81573676"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81330090"],"award-info":[{"award-number":["81330090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.antiviral.2018.04.017","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T22:28:23Z","timestamp":1524608903000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in\u00a0vitro and effectively suppressed HBV replication in mouse model"],"prefix":"10.1016","volume":"155","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-1211","authenticated-orcid":false,"given":"Weiming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penggao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvping","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.04.017_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijpharm.2007.01.021","article-title":"Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers","volume":"337","author":"Borges","year":"2007","journal-title":"Int. J. Phar."},{"key":"10.1016\/j.antiviral.2018.04.017_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1440-1746.2010.06470.x","article-title":"Animal model for study of human hepatitis viruses","volume":"26","author":"Chayama","year":"2011","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2018.04.017_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virusres.2015.12.005","article-title":"Anti-hepatitis B virus effect of matrine-type alkaloid and involvement of p38 mitogen-activated protein kinase and tumor necrosis factor receptor-associated factor 6","volume":"215","author":"Chen","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2018.04.017_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/jvh.12112","article-title":"Anti-HBV effect of individual traditional Chinese herbal medicine in\u00a0vitro and in\u00a0vivo: an analytic review","volume":"20","author":"Chen","year":"2013","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.antiviral.2018.04.017_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/cr.2014.32","article-title":"Generation of neural progenitor cells by chemical cocktails and hypoxia","volume":"24","author":"Cheng","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2018.04.017_bib6","first-page":"39","article-title":"Traditional Chinese medicine and related active compounds against hepatitis B virus infection","volume":"4","author":"Cui","year":"2010","journal-title":"Biosci. Trends."},{"key":"10.1016\/j.antiviral.2018.04.017_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bmcl.2005.11.073","article-title":"(+)-12a- Hydroxysophocarpine, a new quinolizidine alkaloid and related anti-HBV alkaloids from Sophora flavescens","volume":"16","author":"Ding","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2018.04.017_bib8","first-page":"425","article-title":"Establishment of hepatitis B virus (HBV) chronic infection mouse model by in\u00a0vivo transduction with a recombinant adeno-associated virus 8 carrying 1.3 copies of HBV genome (rAAV8-1.3HBV)","volume":"26","author":"Dong","year":"2010","journal-title":"Bing Du. Xue Bao"},{"key":"10.1016\/j.antiviral.2018.04.017_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-0033-1345713","article-title":"New therapeutic targets and drugs for the treatment of chronic hepatitis","volume":"33","author":"Fletcher","year":"2013","journal-title":"B.\u00a0Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2018.04.017_bib10","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.04.017_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2007.01.002","article-title":"Anti-hepatitis B virus activity of wogonin in\u00a0vitro and in\u00a0vivo","volume":"74","author":"Guo","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.017_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1055\/s-2000-9775","article-title":"Anti-hepatitis B virus effects of Wogonin isolated from Scutellaria baicalensis","volume":"66","author":"Huang","year":"2000","journal-title":"Planta Med."},{"key":"10.1016\/j.antiviral.2018.04.017_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2015.08.008","article-title":"Immune-modulators to combat hepatitis B virus infection: from IFN-\u03b1 to novel investigation immunotherapeutic strategies","volume":"122","author":"Isorce","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.017_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cca.2010.10.028","article-title":"Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients","volume":"412","author":"Ji","year":"2011","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.antiviral.2018.04.017_bib15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.exphem.2010.08.010","article-title":"Cdc25A-driven proliferation regulates CD62L levels and lymphocyte movement in response to interleukin-7","volume":"38","author":"Kittipatarin","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.antiviral.2018.04.017_bib16","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","article-title":"Present and future therapies of hepatitis B: from discovery to cure","volume":"62","author":"Liang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.04.017_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.7150\/ijbs.16064","article-title":"An effective molecular target site in hepatitis B virus S gene for Cas9 cleavage and mutational inactivation","volume":"12","author":"Li","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.antiviral.2018.04.017_bib18","article-title":"Removal of integrated hepatitis B virus DNA using CRISPR-Cas9","author":"Li","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.antiviral.2018.04.017_bib19","series-title":"Symposium of the Sixth Annual Conference Proceedings for HIV by Chinese Medical Association AIDS Branch","first-page":"p191","article-title":"Clinical observation for treatment of HIV infection by Sudu-injecta monotherapy","author":"Li","year":"2008"},{"key":"10.1016\/j.antiviral.2018.04.017_bib20","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1128\/JCM.01518-10","article-title":"Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine-and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients","volume":"48","author":"Li","year":"2010","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2018.04.017_bib21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/liv.13104","article-title":"Multidrug resistance protein 4 is a critical protein associated with the antiviral efficacy of nucleos(t)ide analogues","volume":"36","author":"Liu","year":"2016","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2018.04.017_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/jvh.12298","article-title":"The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil","volume":"22","author":"Liu","year":"2015","journal-title":"J.\u00a0Viral Hepat."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.antiviral.2018.04.017_bib23","first-page":"719A","article-title":"Genotypic and phenotypic characteristics of HBV entecavir resistance in Chinese patients","volume":"58","author":"Liu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.04.017_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.antiviral.2018.04.017_bib25","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jhep.2016.02.009","article-title":"Attacking hepatitis B virus cccDNA \u2013 the holy grail to hepatitis B cure","volume":"64","author":"Lucifora","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2018.04.017_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/186573","article-title":"Combining Oxymatrine or Matrine with lamivudine increased its antireplication effect against the hepatitis B virus in\u00a0vitro","volume":"2013","author":"Ma","year":"2013","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"10.1016\/j.antiviral.2018.04.017_bib27","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1093\/cid\/cit002","article-title":"Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus","volume":"56","author":"Matthews","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.04.017_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.antiviral.2018.04.017_bib29","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell. Rep."},{"key":"10.1016\/j.antiviral.2018.04.017_bib30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1365-2362.1997.2020749.x","article-title":"Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors","volume":"27","author":"Ott","year":"1997","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2018.04.017_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2005.07.005","article-title":"Effect of artemisinin\/artesunate as inhibitors of hepatitis B virus production in an \u201cin\u00a0vitro\u201d replicative system","volume":"68","author":"Romero","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.017_bib32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.04.017_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003125","article-title":"The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes","volume":"9","author":"Tavis","year":"2013","journal-title":"PloS Pathog."},{"key":"10.1016\/j.antiviral.2018.04.017_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077298","article-title":"Chimeric mouse model for the infection of hepatitis B and C viruses","volume":"8","author":"Tesfaye","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2018.04.017_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11655-012-1064-4","article-title":"Chinese medicine for treatment of chronic hepatitis B","volume":"18","author":"Wang","year":"2012","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.antiviral.2018.04.017_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2009.05.002","article-title":"Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in\u00a0vivo and in\u00a0vitro","volume":"83","author":"Wang","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.017_bib37","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.foodchem.2011.06.041","article-title":"Identification of the antidiarrhoeal components in official rhubarb using liquid chromatography\u2013tandem mass spectrometry","volume":"129","author":"Wang","year":"2011","journal-title":"Food Chem."},{"issue":"S4","key":"10.1016\/j.antiviral.2018.04.017_bib38","first-page":"1082A","article-title":"Establishment of three hepatoma cell lines stably replicating wild-type, entecavir-resistant or multidrug-resistant genotype C hepatitis B viruses","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.04.017_bib39","first-page":"95","article-title":"Anti-HBV effect of nucleotide analogues on mouse model of chronic HBV infection mediated by recombinant adeno-associated virus 8","volume":"29","author":"Wang","year":"2013","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"10.1016\/j.antiviral.2018.04.017_bib40","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1128\/AAC.01764-09","article-title":"Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus","volume":"54","author":"Wang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.04.017_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.antiviral.2011.01.005","article-title":"Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance","volume":"89","author":"Wang","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.017_bib42","series-title":"Data Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection","author":"WHO","year":"2015"},{"key":"10.1016\/j.antiviral.2018.04.017_bib43","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3748\/wjg.v16.i16.2028","article-title":"Effect of oxymatrine on the replication cycle of hepatitis B virus in\u00a0vitro","volume":"16","author":"Xu","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2018.04.017_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cmi.2013.43","article-title":"A\u00a0mouse model for HBV immunotolerance and immunotherapy","volume":"11","author":"Yang","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2018.04.017_bib45","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bmc.805","article-title":"LC-MS Characterization of efficacy substances in serum of experimental animals treated with Sophora flavescens extracts","volume":"21","author":"Ye","year":"2007","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.antiviral.2018.04.017_bib46","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1073\/pnas.0609883104","article-title":"Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue","volume":"104","author":"Ying","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.04.017_bib47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jep.2014.08.043","article-title":"UFLC\/MS-IT-TOF guided isolation of anti-HBV active chlorogenic acid analogues from Artemisia capillaris as a traditional Chinese herb for the treatment of hepatitis","volume":"156","author":"Zhao","year":"2014","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.antiviral.2018.04.017_bib48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jep.2014.03.011","article-title":"Spectrum-effect relationships between UPLC fingerprints and bioactivities of crude secondary roots of Aconitum carmichaelii Debeaux (Fuzi) and its three processed products on mitochondrial growth coupled with canonical correlation analysis","volume":"153","author":"Zheng","year":"2014","journal-title":"J.\u00a0Ethnopharmacol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217305302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217305302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:55Z","timestamp":1759062415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217305302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":48,"alternative-id":["S0166354217305302"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.017","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in\u00a0vitro and effectively suppressed HBV replication in mouse model","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}